Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Liabilities from Discontinued Operations (2020 - 2022)

Integra Lifesciences Holdings' Liabilities from Discontinued Operations history spans 3 years, with the latest figure at 2303000.0 for Q2 2022.

  • For Q2 2022, Liabilities from Discontinued Operations changed N/A year-over-year to 2303000.0; the TTM value through Jun 2022 reached 2303000.0, changed N/A, while the annual FY2020 figure was 11751000.0, N/A changed from the prior year.
  • Liabilities from Discontinued Operations for Q2 2022 was 2303000.0 at Integra Lifesciences Holdings, down from 11751000.0 in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at 12349000.0 in Q3 2020 and bottomed at 2303000.0 in Q2 2022.